Expansion of a polymorphic polyglutamine segment is the common denominator of neurodegenerative polyglutamine diseases. The expanded proteins typically accumulate in large intranuclear inclusions and induce neurodegeneration. However, the mechanisms that determine the subcellular site and rate of inclusion formation are largely unknown. We found that the conserved putative nuclear localization sequence Arg-LysArg-Arg, which is retained in a highly aggregation-prone fragment of ataxin-3, did not affect the site and degree of inclusion formation in a cell culture model of spinocerebellar ataxia type 3. Addition of synthetic nuclear export or import signals led to the expected localization of ataxin-3 and determined the subcellular site of aggregate formation. Triggering a cellular stress response by heat shock transcription factor ⌬HSF1 coexpression abrogated aggregation in the cytoplasm but not in the nucleus. These findings indicate that native aggregation-prone fragments derived from expanded ataxin-3 may eventually escape the cytoplasmic quality control, resulting in aggregation in the nuclear compartment.Many human diseases are caused by the continuous expression of misfolded or misfolding-sensitive proteins (for review, see Ref. 1). The related polyglutamine (polyQ) 3 family of neurodegenerative diseases is caused by expansion of a variable polyQ segment above a threshold of typically ϳ40 residues. These expansions render the otherwise unrelated proteins susceptible to adopt non-native conformations that eventually become toxic or form toxic oligomers and aggregates. Large aggregates arise as intracellular inclusion bodies that are composed mainly of the mutant protein but also contain many other proteins, including transcription factors (2), molecular chaperones, and components of the ubiquitin-proteasome system (3). Several cellular pathways, including transcriptional dysregulation, inhibition of protein degradation, impairment of energy metabolism, and activation of cell death programs, have been implicated in the molecular mechanisms of the neurodegenerative processes caused by polyQ-expanded proteins (for review, see Ref. 4). These variations are likely determined by sequences outside the polyQ tract, which are specific for the individual disease proteins (5, 6). Even though toxicity has been experimentally dissociated from detectable inclusion body formation (e.g. Refs. 7 and 8), the hallmark of polyQ diseases is the characteristic formation of intraneuronal inclusions, most often in the nuclear compartment. Hence, it seems reasonable to argue that an imbalance in the production of toxic aggregation intermediates and their clearance constitutes the fundamental commonality of these diseases (9). Notably, the aggregation products accumulate, although cells are equipped with an elaborate network of molecular chaperones and cofactors with sufficient capacity to maintain a balanced protein homeostasis essential to cellular function (9, 10). Increasing evidence suggests that the nuclear compartment is the pr...